|
|
||||||||
Original Research |
1 All authors: The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins School of Medicine, 601 N Caroline St., Rm. 3251, Baltimore, MD 21287.
Received May 24, 2007;
accepted after revision September 24, 2007.
Address correspondence to E. K. Fishman
(efishman{at}jhmi.edu).
Abstract
|
|
|---|
MATERIALS AND METHODS. Sites in the United States that perform 64-MDCT coronary angiography were surveyed by mail in 2006. Information requested included physician specialty; experience level; details about patient preparation, including the use, dose, route, and timing of premedication; and acceptable heart rate and rhythm. A total of 142 surveys were analyzed, with comparison of parameters across specialties (radiology, cardiology, or shared) and experience levels.
RESULTS. All facets of the study (premedication, data acquisition,
cardiac interpretation) are performed exclusively by radiologists in 49% of
sites and by cardiologists in 14%. All sites administer β-blockers.
Target heart rate was reported as
65 beats per minute (bpm) by 89% of
responders. Despite most centers aiming for a heart rate of
65 bpm, the
maximum allowable heart rate is > 65 bpm in 80% of centers. Patients with
arrhythmia are scanned in at least 25% of sites. Most sites (84%) administer
nitroglycerin. Significant differences between specialties were noted for
experience levels, timing and route of β-blocker administration, and for
target heart rate. The likelihood of scanning in the setting of arrhythmia and
β-blocker timing correlated with experience levels.
CONCLUSION. These 64-MDCT coronary artery data from 2006 reveal
consensus for a range of patient preparation parameters. Use of
β-blockers and nitroglycerin is routine, and the target heart rate is
usually
65 bpm. However, differences were noted for β-blocker
protocols and acceptable heart rate and rhythm, and some differences in
practice are associated with experience level and specialty.
Keywords: coronary artery CT CT angiography practice questionnaire
|
|
|---|
Unlike other new CT angiography applications made possible by advances in technology during the past decade, coronary artery imaging with MDCT is far more complicated than simply modifying the acquisition parameters and IV contrast infusion protocols for a new anatomic region. Compounding variables include the requirement for a controlled heart rate, a regular heart rhythm, and carefully timed arterial enhancement during maximal arterial perfusion and minimal cardiac motion. After data acquisition, multiple reconstructions may be necessary to optimize the evaluation of each coronary region for interpretation using a range of display and rendering techniques. Because of the numerous factors playing a role in these challenging studies, we sought to assess current practice characteristics for each component of the examination through a nationwide survey.
|
|
|---|
|
Potential relationships between survey variables were evaluated using the Fisher's exact test from two-way cross-tabulations of the data. A p value of less than 0.05 was considered statistically significant.
|
|
|---|
Of the sites responding, all roles (premedication, data acquisition, and study interpretation) are performed exclusively by radiologists in 49% (66/134) and cardiologists in 14% (19/134) of sites. The remainder of the centers apportioned facets of the study as shown in Table 1. Medications are administered exclusively by radiologists in 56% (79/140), exclusively by cardiologists in 24% (33/140), and medication administration is shared by both specialties in 19% (27/140) of sites. One center has the referring physician perform premedication.
|
Most sites had low (44%, 59/135) or moderate (41%, 55/135) levels of experience, with a high experience level reported by 16% (21/135). Of the 20 high-experience sites indicating specialty, 55% (11/20) are cardiology sites and 30% (6/20) are radiology sites. The relationship between site specialty and experience level was statistically significant (p < 0.001) (Table 2).
|
Beta-blockers are used by all sites for heart rate control. Respondents provided varying degrees of detail in describing the dose and timing. Among the 119 oral β-blocker protocols described, most sites simply reported dose and timing. However, a number detailed some degree of dependence on heart rate (13%, 15/119), weight (2%, 2/119), or both (1%, 1/119). Additional evidence that patient variables affect dose include the incremental administration of subsequent doses over time performed by 4% (5/119) and a range of doses provided by 20% (24/119) of sites. The route of administration, reported by 139 sites, is most commonly oral supplemented by IV (53%, 73/139). Again, respondents provided a range of detail. Slightly more than half (53%, 39/73) specifically described that IV β-blocker use after oral medication was heart rate–dependent, and the remainder either listed the dose (+/– timing of administration) (23/73) or provided no IV dose or timing details (11/73). Oral β-blockers only are used by 36% (50/139); and the least common practice is to administer IV only (12%, 16/139), with five of these sites reporting that the medication was administered only as needed.
Analysis according to specialty revealed that cardiologists are more likely than radiologists to supplement oral β-blockers with IV. Of the centers using oral β-blockers, IV β-blockers are potentially administered by 87% (27/31) of cardiologists, 41% (28/69) of radiologists, and 85% (17/20) of sites where medication administration is shared. However, no participating site where cardiologists exclusively administer medication uses IV β-blockers only. A statistically significant difference (p < 0.001) was identified for route of β-blocker administration when correlated with specialty (radiology, cardiology, or shared). Significant differences across experience levels were not identified (p = 0.07).
Of the 115 sites that indicated timing for oral β-blocker administration, 68% (78/115) give the first dose on the day of the examination, most commonly 1 hour before CT (77%, 60/78). The initial dose is administered either the day or the evening before the examination by 32% (37/115). Cardiologists and sites with high experience levels were more likely to begin premedication on the day before CT. Differences were statistically significant across specialty (p < 0.001) and experience levels (p = 0.006).
Table 3 shows the range of
target heart rates using best-fit categories; 89% of sites (126/141) aim for a
heart rate
65 bpm, with a median value of 60 bpm (n = 53). Of
note, cardiologists consistently (32/32) use a target heart rate of
65
bpm, whereas 18% (14/79) of radiologists set a higher target. Using categories
of
65 and > 65 bpm, differences in target heart rate across specialty
were statistically significant (p = 0.007), but no significant
differences were seen across experience levels (p = 0.7).
|
Despite the target heart rate commonly being
65 bpm, the maximum
allowable heart rate, reported by 141 centers, ranged from 59 bpm to any heart
rate (Table 4). A cutoff higher
than 65 bpm is used by 80% (113/141) of sites. The most commonly reported
values were 65 (n = 15), 70 (n = 36), 75 (n = 16),
and 80 (n = 15) bpm. Using categories of < 75, 75–80, and
> 80 bpm, no significant difference was seen in experience level or
specialty that dictated the maximum allowable heart rate (p =
0.4–0.7).
|
When asked if they scan patients with arrhythmias, 25% (35/138) of sites simply answered yes, 6% (8/138) supplemented the answer by writing that they scan only with ectopic beats (n = 7) or bradycardia (n = 1), and 38% (53/138) answered no. The remaining 30% (42/138) wrote in a conditional response. Although the difference in practice was significant across experience levels (p = 0.006), data analysis did not reveal a practice pattern evolving from increasing level of experience (Table 5).
|
With respect to other medications, 84% (119/142) of centers administer nitroglycerin. Of the 131 centers who responded to the question about whether they use calcium channel blockers, 27% (35/131) reported they do, and 26% of these (9/35) wrote that this was only in the setting of a β-blocker contraindication. Other medications, reported by 14 centers, include benzodiazepines (n = 6), lidocaine (n = 5), Mucomyst [acetylcysteine, Bristol-Myers Squibb] (n = 2), atropine (n = 2), and digoxin (n = 1).
|
|
|---|
The increased speed of 16-MDCT over earlier generation MDCT scanners did
not obviate the requirement for heart rate control
[12–15],
and neither has 64-MDCT technology, according to published studies
[11,
16]. With 16-MDCT, a heart
rate < 80 bpm minimizes motion artifact, but highest image quality was seen
in patients with a mean heart rate of 60 bpm
[12]. Cademartiri et al.
[13] have also shown that
increasing heart rate decreases diagnostic accuracy. In patients who have not
received β-blockers and have a heart rate > 64–68.5 bpm,
reconstruction of data during end-systole or early diastole improves image
quality [14]. Using 64-MDCT, a
heart rate of
65 bpm results in significantly improved image quality for
the left anterior descending, left circumflex, and right coronary arteries
[11]. Control of heart rate
and rhythm with β-blockers has been shown to increase the percentage of
coronary segments with acceptable 16-MDCT image quality from 58–96% to
87–100%, depending on the arterial territory
[15]. Using 64-MDCT, patients
receiving β-blockers as part of their baseline medications had
significantly decreased heart rate variability, resulting in improved image
quality for all vessels
[16].
Accordingly, it is not surprising that all centers administer β-blockers. Among the centers surveyed, a greater percentage of examinations are performed by radiologists (Table 1), accounting for the higher percentage of radiologists administering premedication. The route varies across specialty, and cardiologists more commonly supplement oral β-blockers with IV. Theoretic explanations for more frequent supplementation with IV β-blockers by cardiologists include a higher comfort level in administering the medication IV and that the target heart rate was uniformly lower among cardiologists. Future analysis of the remaining data from the survey will be used to determine whether the scanner site (inpatient vs outpatient) has an impact on the premedication regimen. The practice of initiating oral β-blockers the day before the study is facilitated by cardiologists' knowledge of the patient's medical history and current medications, and their access to the patient before the study.
At the time of this survey, when experience levels were lower, cardiology sites comprised the majority of those with high experience levels. Several explanations are possible. Before implementing 64-MDCT, a cardiology practice likely determines that they have adequate volume to support utilization. Furthermore, their scanners are probably dedicated to cardiac CT, whereas a radiology department's CT volume includes other regions of the body.
A notable discrepancy was identified when comparing target heart rate with
maximum allowable heart rate. Despite the usual goal of
65 bpm, both
radiologists and cardiologists, and sites with all experience levels, will
scan across a range of heart rates. Nearly one third of centers scan patients
with arrhythmias; however, we did not inquire about the specific rhythm
irregularities that were deemed acceptable in each center. Correlation of
results with experience level revealed significant differences; however, this
analysis did not reflect a pattern evolving from increasing experience level.
A lack of consensus among experts with respect to scanning in the setting of
an arrhythmia persists even a year after this survey was conducted. It would
be useful to determine more detailed information from highly experienced sites
with respect to specific rhythm irregularities that are more or less amenable
to 64-MDCT angiography.
Nitroglycerin is routinely administered (84% of sites) and has been recommended because it significantly increases the diameter of the proximal coronary artery at MDCT [17]. A small percentage of sites (27%) reported that they administer calcium channel blockers. Although some listed their division's indications for this medication, the survey did not inquire in detail about whether this was a routinely administered medication or limited to patients with contraindications to β-blockers (the latter probably because β-blockers are more effective). Few centers listed other medications, most commonly anxiolytics or lidocaine to suppress ectopy.
This study has several limitations. Administration of the survey by a radiology department may have enhanced the percentage of radiologists responding; however, participating cardiologists expressed enthusiasm for the study. Analysis of the data elucidated details that were lacking from the questionnaire, including the heart rate threshold that dictates β-blocker administration in each division, whether additional β-blockers are administered to those who routinely take these medications, whether calcium channel blockers were administered on an as-needed basis or routinely, and who dictates the maximum allowable heart rate and acceptable heart rhythm (physician administering β-blocker or physician acquiring CT data set). The response rate might have been higher; however, our rate of 27% is similar to that of a recent nationwide survey on CT pulmonary angiography [18] and is within the range of other CT practice surveys [19–22]. The response rate was per-letter rather than per-institution, and because the questionnaires were designed to be anonymous, we are unable to determine the response rate per institution. At least four participating institutions that received multiple surveys contacted us and were instructed to submit only one survey, despite the fact that they had multiple 64-MDCT scanners performing coronary CTA. Also, additional sites that were sent letters may have implemented 64-MDCT but were not yet using it to perform coronary angiography. We believe that our method of querying sites that have installed the technology was sufficient to survey the maximum number of sites performing MDCT coronary angiography at this time.
In conclusion, our data suggest that radiologists constituted a larger
percentage of sites performing MDCT coronary angiography in 2006. However, a
greater percentage of the cardiology centers that participated in this study
had high experience levels at the time of the survey. Routine practice
includes administration of β-blockers and nitroglycerin before scanning.
Cardiologists frequently administer the first oral β-blocker dose the day
or night before the study and are more likely to supplement an oral
β-blocker with an IV β-blocker. The target heart rate before
performance of 64-MDCT is usually
65 bpm, particularly among
cardiologists. Results revealed considerable variation in acceptable heart
rate and rhythm for scanning. Despite the fact that coronary artery MDCT is a
new procedure, the consensus for many key parameters suggests that the basics
of the study are becoming well defined. These findings should facilitate
implementation by new sites beginning this practice because they can build on
the experience of others.
|
|
|---|
This article has been cited by other articles:
![]() |
P. T. Johnson, H. K. Pannu, and E. K. Fishman IV Contrast Infusion for Coronary Artery CT Angiography: Literature Review and Results of a Nationwide Survey Am. J. Roentgenol., May 1, 2009; 192(5): W214 - W221. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Stanley Reflections on This Month's Wealth of Content Am. J. Roentgenol., March 1, 2008; 190(3): 555 - 555. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |